Proprietary formulation research
The programme is built around a proprietary topical formulation platform and the research questions documented in the existing scientific materials.
The ErpeCream Investigational Pharmaceutical Development Programme is presented here as separate from ErpeCream / E-Cream cosmetic product commercialization. ACS Biomed is exploring pharmaceutical licensing and co-development opportunities around proprietary formulation research, laboratory investigations and preliminary clinical research.
The programme is built around a proprietary topical formulation platform and the research questions documented in the existing scientific materials.
Existing project materials describe laboratory investigations and preliminary clinical research. The current page does not add a new trial status, location, recruitment figure or approval claim.
The objective is to establish an evidence-led path for future pharmaceutical development with an experienced licensing or co-development partner.